Literature DB >> 17196922

Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometry.

Daniela Schreiber1, Stephanie Harlfinger, Brit M Nolden, Christoph W Gerth, Ulrich Jaehde, Edgar Schömig, Joachim Klosterkötter, Andrea Giuffrida, Giuseppe Astarita, Daniele Piomelli, F Markus Leweke.   

Abstract

We developed a new selective liquid chromatography-electrospray ionization-tandem mass spectrometry method for the identification and quantification of anandamide (AEA), an endogenous cannabinoid receptor ligand, and other bioactive fatty acid ethanolamides (FAEs) in biological samples. Detection limit (0.025 pmol for AEA and 0.1 pmol for palmitoylethanolamide (PEA) and oleoylethanolamide (OEA)) and quantification limit (0.2 pmol for AEA and 0.4 pmol for OEA and PEA) were in the high fmol to low pmol range for all analytes. Linear correlations (r(2)=0.99) were observed in the calibration curves for standard AEA over the range of 0.025-25 pmol and for standard PEA and OEA over the range of 0.1-500 pmol. This method provides a time-saving and sensitive alternative to existing methods for the analysis of FAEs in biological samples.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17196922     DOI: 10.1016/j.ab.2006.11.027

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  16 in total

Review 1.  The endocannabinoid system as a target for modelling psychosis.

Authors:  Dagmar Koethe; Carolin Hoyer; F Markus Leweke
Journal:  Psychopharmacology (Berl)       Date:  2009-06-16       Impact factor: 4.530

2.  Optimized extraction of 2-arachidonyl glycerol and anandamide from aortic tissue and plasma for quantification by LC-MS/MS.

Authors:  Christopher Garst; Makenzie Fulmer; Doug Thewke; Stacy Brown
Journal:  Eur J Lipid Sci Technol       Date:  2015-08-28       Impact factor: 2.679

3.  Increased CB2 mRNA and anandamide in human blood after cessation of cannabis abuse.

Authors:  Daniela Muhl; Markus Kathmann; Carolin Hoyer; Laura Kranaster; Martin Hellmich; Christoph W Gerth; Johannes Faulhaber; Eberhard Schlicker; F Markus Leweke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-05-02       Impact factor: 3.000

Review 4.  The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.

Authors:  Stefania Petrosino; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2016-09-29       Impact factor: 8.739

5.  Endocannabinoids as potential biomarkers: It's all about pre-analytics.

Authors:  Daniel Kratz; Dominique Thomas; Robert Gurke
Journal:  J Mass Spectrom Adv Clin Lab       Date:  2021-11-10

Review 6.  Lipidomic analysis of endocannabinoid metabolism in biological samples.

Authors:  Giuseppe Astarita; Daniele Piomelli
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-01-14       Impact factor: 3.205

7.  Quantitative LC-MS/MS analysis of arachidonoyl amino acids in mouse brain with treatment of FAAH inhibitor.

Authors:  Bingnan Han; Rachel Wright; Aaron M Kirchhoff; Julia A Chester; Bruce R Cooper; Vincent Jo Davisson; Eric Barker
Journal:  Anal Biochem       Date:  2012-10-05       Impact factor: 3.365

8.  Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters.

Authors:  JodiAnne T Wood; John S Williams; Lakshmipathi Pandarinathan; Amber Courville; Melissa R Keplinger; David R Janero; Paul Vouros; Alexandros Makriyannis; Carol J Lammi-Keefe
Journal:  Clin Chem Lab Med       Date:  2008       Impact factor: 3.694

Review 9.  Analysis of endocannabinoids, their congeners and COX-2 metabolites.

Authors:  Philip J Kingsley; Lawrence J Marnett
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-05-21       Impact factor: 3.205

10.  Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid.

Authors:  Dagmar Koethe; Daniela Schreiber; Andrea Giuffrida; Christian Mauss; Johannes Faulhaber; Bernd Heydenreich; Martin Hellmich; Rudolf Graf; Joachim Klosterkötter; Daniele Piomelli; F Markus Leweke
Journal:  J Neural Transm (Vienna)       Date:  2009-01-10       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.